Claudia Martini
Papers
1
Total Citations
30
H-Index
1
About
Claudia Martini is a leading figure in radiochemistry and molecular imaging, whose work has significantly advanced the development of novel positron emission tomography (PET) radiotracers for neuroinflammation. Her primary research focuses on the design and synthesis of fluorine-18 labeled compounds targeting the translocator protein (TSPO) 18 kDa, a key biomarker for activated microglia in neurological disorders. Martini’s most cited work, the 2011 synthesis of 6-[18F]fluoro-PBR28, introduced a critical radiotracer for non-invasive TSPO imaging, enabling researchers to visualize neuroinflammatory processes with high specificity. This contribution, garnering over 30 citations, laid the groundwork for clinical studies in conditions like Alzheimer’s disease and multiple sclerosis. Beyond this landmark achievement, Martini has pioneered methods to improve radiolabeling efficiency and metabolic stability, directly impacting the translational success of PET probes. Her interdisciplinary approach bridges organic chemistry and neuroscience, making her a sought-after collaborator in both academic and clinical settings. For students and researchers, Martini’s work exemplifies how precise chemical innovation can unlock new windows into brain pathology, offering tools that are now essential for studying neuroinflammation in living subjects.
Research Focus
Key Achievements
Top Papers
- 1